Warning letter
Christus St. Patrick Hoospital: warning letter of Aug 29, 2000
FDA warning letter UCM068783 · Center for Biologics Evaluation and Research
Key facts
| Reference number | UCM068783 |
|---|---|
| Company | Christus St. Patrick Hoospital |
| Subject | IRB (Institutional Review Board) |
| Issue date | Aug 29, 2000 |
| Posted date | Aug 29, 2000 |
| Issuing office | Center for Biologics Evaluation and Research |
| Product type | Biologics |
| CFR sections cited | 50, 56, 56.109, 56.110, 56.115, 56.120, 56.102(d), 56.104(c), 56.108(a), 56.109(f), 56.115(a)(2), 56.115(a)(5) and 2 more |
| Country | 3 |
| Inspection city | Lake Charles |
| Inspection ZIP | 70601-5725 |
| Inspection start date | Apr 17, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: